Fast-route market entry for a new family of anti-pathogenic materials
| Reference number | |
| Coordinator | NanoForm Science AB |
| Funding from Vinnova | SEK 300 000 |
| Project duration | June 2020 - February 2021 |
| Status | Completed |
| Venture | Innovative Startups |
| Call | Innovative Startups step 1 spring 2020 |
Important results from the project
** Denna text är maskinöversatt ** NanoForm Science has together with Karolinska Hospital prepared validation tests of an anti-pathogen coating that strongly reduces the spread of viruses such as SARS-COV-2, but also antibiotic-resistant bacteria. A small preparatory test was conducted together with the hospital to validate functionality, with good results. Contact has been established with a hospital in Congo and tests will take place in 2021. The company has carried out an IP analysis with an external expert and discussions have been initiated with industry partners.
Expected long term effects
** Denna text är maskinöversatt ** Sample material was prepared - partly successful. A process problem was identified that made initial tests not 100% successful. However, a solution was identified and will be evaluated in the next round of large-scale tests. Identification of suitable test environments in hospitals - Successful. An analysis has been carried out with KS and several relevant environments have been identified. IP analysis and patent preparation - Successful. An IP analysis has been carried out and an understanding of where possible patents should be placed is in place.
Approach and implementation
** Denna text är maskinöversatt ** The project has included the preparation of a test with a hospital. Due to COVID-19, there was a delay, but an minor test has been carried out as part of the preparations (involved less resources from KS). The results were positive and both parties have a good idea of how larger tests can be done. In addition, preparations for tests with University Hospital in Congo have begun. More tests will take place during Q1 2021, incl. ISO test. An IP analysis was conducted with an external party at the same time as a regulatory / business analysis was performed internally.